Suchergebnisse - "Pinato, David J"

PubPharm (104)

41

COVID-19 and Cancer : A Review of the Registry-Based Pandemic Response

enthalten in: JAMA oncology | 2021

von Desai, A. | Mohammed, T. | Duma, N. | +12

42

Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer : A Multicenter International Cohort Study

enthalten in: JAMA oncology | 2021

von Nebhan, C. | Cortellini, A. | Ma, W. | +42

43

Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Hashimoto, A. | Sarker, D. | Reebye, V. | +28

44

Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer : Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Pinato, D. | Marron, T. | Mishra-Kalyani, P. | +39

45

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma : implications for immunotherapy

enthalten in: Journal for immunotherapy of cancer | 2021

von Pinato, D. | Murray, S. | Forner, A. | +18

46

Immunotherapy in Hepatocellular Carcinoma

enthalten in: Current treatment options in oncology | 2021

von Fulgenzi, C. | Talbot, T. | Murray, S. | +4

47

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma : a comparison of outcomes

enthalten in: BJU international | 2021

von Esagian, S. | Khaki, A. | Diamantopoulos, L. | +43

48

Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma

enthalten in: Hepatology (Baltimore, Md.) | 2021

von Pinato, D. | Fessas, P. | Sapisochin, G. | +1

49

Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer

enthalten in: Science translational medicine | 2021

von Chrysostomou, S. | Roy, R. | Prischi, F. | +40

CommentIn: Nat Rev Drug Discov. 2021 Sep;20(9):666. - PMID 34354258

50

Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab

enthalten in: Journal for immunotherapy of cancer | 2021

von Alexander, J. | Ibraheim, H. | Sheth, B. | +20